Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
Expert Opinion on Biological Therapy
|
May 15, 2008
Complement and cellular cytotoxicity in antibody therapy of cancer
Siao-Yi Wang, George Weiner
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
May 11, 2011
Active choice but not too active: public perspectives on biobank consent models
Christian M Simon, Jamie L'heureux, Jeffrey C Murray, et al.
Journal of the National Cancer Institute
|
July 28, 2022
Leadership Diversity and Development in the Nation's Cancer Centers
Caryn Lerman, Chanita Hughes-Halbert, Mary Falcone, et al.
Plos One
|
October 17, 2013
Identification of candidate B-lymphoma genes by cross-species gene expression profiling
Van S Tompkins, Seong-Su Han, Alicia Olivier, et al.
Blood
|
July 5, 2011
Multi-institutional phase 2 study of the farnesyltransferase inhibitor tipifarnib (R115777) in patients with relapsed and refractory lymphomas
Thomas E Witzig, Hui Tang, Ivana N M Micallef, et al.
Research Square
|
June 12, 2026
The Oncology Research Information Exchange Network (ORIEN) - Building a real-world collaborative, patient-driven infrastructure for discovery research and precision oncology
Michelle Churchman, Xin Lu, David McKean, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
Expert Opinion on Biological Therapy
|
May 15, 2008
Complement and cellular cytotoxicity in antibody therapy of cancer
Siao-Yi Wang, George Weiner
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
May 11, 2011
Active choice but not too active: public perspectives on biobank consent models
Christian M Simon, Jamie L'heureux, Jeffrey C Murray, et al.
Journal of the National Cancer Institute
|
July 28, 2022
Leadership Diversity and Development in the Nation's Cancer Centers
Caryn Lerman, Chanita Hughes-Halbert, Mary Falcone, et al.
Plos One
|
October 17, 2013
Identification of candidate B-lymphoma genes by cross-species gene expression profiling
Van S Tompkins, Seong-Su Han, Alicia Olivier, et al.
Blood
|
July 5, 2011
Multi-institutional phase 2 study of the farnesyltransferase inhibitor tipifarnib (R115777) in patients with relapsed and refractory lymphomas
Thomas E Witzig, Hui Tang, Ivana N M Micallef, et al.
Research Square
|
June 12, 2026
The Oncology Research Information Exchange Network (ORIEN) - Building a real-world collaborative, patient-driven infrastructure for discovery research and precision oncology
Michelle Churchman, Xin Lu, David McKean, et al.
Page
of 1